Observational Study to Evaluate Use of Elidel ® in South and East Asian Pediatric Patients With Atopic Dermatitis.
Conditions: Mild to Moderate Atopic Dermatitis Interventions: Drug: Elidel 1% Topical Cream Sponsors: MEDA PHARMA SPA, a Viatris company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 25, 2023 Category: Research Source Type: clinical trials
Clinical Investigation on the Treatment of Radiation Induced Dermatitis With FR-101 Chest Dressing
Conditions: Breast Cancer; Radiation Dermatitis Intervention: Device: FR-101 Chest Dressing Sponsor: China Medical University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials
Anti-Inflammatory Effects of 0.045% Tazarotene/0.01% Halobetasol Lotion in Psoriasis
Condition: Psoriasis Vulgaris Interventions: Drug: 0.01% Halobetasol; Drug: 0.045% Tazarotene; Drug: 0.05% Clobetasol Propionate Sponsor: Dermatology Consulting Services, PLLC Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials
Clinical Investigation on the Treatment of Radiation Induced Dermatitis With FR-101 Chest Dressing
Conditions: Breast Cancer; Radiation Dermatitis Intervention: Device: FR-101 Chest Dressing Sponsor: China Medical University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials
Anti-Inflammatory Effects of 0.045% Tazarotene/0.01% Halobetasol Lotion in Psoriasis
Condition: Psoriasis Vulgaris Interventions: Drug: 0.01% Halobetasol; Drug: 0.045% Tazarotene; Drug: 0.05% Clobetasol Propionate Sponsor: Dermatology Consulting Services, PLLC Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials
Clinical Investigation on the Treatment of Radiation Induced Dermatitis With FR-101 Chest Dressing
Conditions: Breast Cancer; Radiation Dermatitis Intervention: Device: FR-101 Chest Dressing Sponsor: China Medical University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials
Anti-Inflammatory Effects of 0.045% Tazarotene/0.01% Halobetasol Lotion in Psoriasis
Condition: Psoriasis Vulgaris Interventions: Drug: 0.01% Halobetasol; Drug: 0.045% Tazarotene; Drug: 0.05% Clobetasol Propionate Sponsor: Dermatology Consulting Services, PLLC Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials
Clinical Investigation on the Treatment of Radiation Induced Dermatitis With FR-101 Chest Dressing
Conditions: Breast Cancer; Radiation Dermatitis Intervention: Device: FR-101 Chest Dressing Sponsor: China Medical University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials
Anti-Inflammatory Effects of 0.045% Tazarotene/0.01% Halobetasol Lotion in Psoriasis
Condition: Psoriasis Vulgaris Interventions: Drug: 0.01% Halobetasol; Drug: 0.045% Tazarotene; Drug: 0.05% Clobetasol Propionate Sponsor: Dermatology Consulting Services, PLLC Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials
Clinical Investigation on the Treatment of Radiation Induced Dermatitis With FR-101 Chest Dressing
Conditions: Breast Cancer; Radiation Dermatitis Intervention: Device: FR-101 Chest Dressing Sponsor: China Medical University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials
Anti-Inflammatory Effects of 0.045% Tazarotene/0.01% Halobetasol Lotion in Psoriasis
Condition: Psoriasis Vulgaris Interventions: Drug: 0.01% Halobetasol; Drug: 0.045% Tazarotene; Drug: 0.05% Clobetasol Propionate Sponsor: Dermatology Consulting Services, PLLC Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials
Clinical Investigation on the Treatment of Radiation Induced Dermatitis With FR-101 Chest Dressing
Conditions: Breast Cancer; Radiation Dermatitis Intervention: Device: FR-101 Chest Dressing Sponsor: China Medical University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials
Anti-Inflammatory Effects of 0.045% Tazarotene/0.01% Halobetasol Lotion in Psoriasis
Condition: Psoriasis Vulgaris Interventions: Drug: 0.01% Halobetasol; Drug: 0.045% Tazarotene; Drug: 0.05% Clobetasol Propionate Sponsor: Dermatology Consulting Services, PLLC Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials
Clinical Investigation on the Treatment of Radiation Induced Dermatitis With FR-101 Chest Dressing
Conditions: Breast Cancer; Radiation Dermatitis Intervention: Device: FR-101 Chest Dressing Sponsor: China Medical University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials